权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Renal AT2 Receptors in Hypertension

高血压中的肾 AT2 受体

基本信息

批准号：
8441622
负责人：
ROBERT MUNSON CAREY
金额：
$ 40.24万
依托单位：
UNIVERSITY OF VIRGINIA
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-04-15 至 2014-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8441622
关键词：
AGTR2 gene Adult Affect Age Agonist Angiotensin II Angiotensin III Animals Apical Blood Pressure Blood Vessels Blood capillaries Cell Proliferation Cell membrane Cells Cessation of life Data Defect Development Disease Dopamine Dopamine D1 Receptor Electrolyte Balance Electrolytes End stage renal failure Enzymes Essential Hypertension Excretory function Exhibits Fenoldopam Fluid Balance Functional disorder Goals Heart Heart failure Hormonal Human Hypertension Inbred SHR Rats Inbred Strain Infusion procedures Kidney Laboratories Lead Ligands Liquid substance Mediating Mediator of activation protein Modeling Molecular Molecular Target Myocardial Infarction Natriuresis Nephrons Peptides Perfusion Play Population Principal Investigator Proximal Kidney Tubules Rattus Receptor Activation Receptor Inhibition Recruitment Activity Regulation Renal function Renin-Angiotensin System Risk Risk Factors Rodent Role Site Sodium Sodium Chloride Sprague-Dawley Rats Stimulus Stroke Techniques Testing Time Transplantation Vasodilation Water Western World alanine aminopeptidase apical membrane blood pressure regulation capillary cell growth disability hypertension prevention in vivo premature pressure public health relevance receptor receptor expression response saluretic urinary vasoconstriction

项目摘要

DESCRIPTION (provided by applicant): The renin-angiotensin system (RAS) is a hormonal cascade of major critical importance to the regulation of blood pressure, fluid and electrolyte balance and kidney function. Angiotensin II (Ang II), the main effector peptide of the RAS, acts at two major receptors, AT1 and AT2. The vast majority of Ang II actions are mediated by the AT1 receptor, including cell proliferation, vasoconstriction and antinatriuresis. Much less is known concerning the functions of the AT2 receptor. Recent studies indicate that the AT2 receptor inhibits cell growth and induces vasodilation opposing the effects of Ang II at AT1 receptors. The role of the AT2 receptors in fluid and electrolyte homeostatsis is unknown. The Principal Investigator has preliminary data demonstrating that the AT2 receptor mediates natriuresis in normal Sprague-Dawley rats and that the heptapeptide derivative of Ang II, des-aspartyl-Ang II (Ang III), is the preferred agonist. The Principal Investigator also has preliminary data strongly suggesting that dopamine D1-receptor stimulation induces increased renal proximal tubule cell apical membrane AT2 receptor expression and that inhibition of AT2 receptors abolishes D1 receptor-induced natriuresis. This project will explore in depth the site and mechanisms of AT2 receptor-induced natriuresis. The project will focus on two specific hypotheses: (1) AT2 receptors in the renal proximal tubule are key mediators of the natriuretic responses to Ang III, AT1 receptor blockade, D1 receptor activation and increased renal perfusion pressure; and (2) AT2 receptor-mediated natriuresis is defective in young pre-hypertensive spontaneously hypertensive rats (SHR). The project will apply a combination of state-of-the-art in vivo and cell and molecular techniques to clarify the role of the AT2 receptor in sodium excretion in hypertension. These studies will help clarify the pathophysiology of human primary hypertension, a disorder affecting one-quarter after adult population in the Western world.

描述(申请人提供)：肾素-血管紧张素系统(RAS)是一种荷尔蒙级联反应，对调节血压、液体和电解质平衡以及肾功能至关重要。血管紧张素II(Ang II)是RAS的主要效应肽，作用于AT1和AT2两个主要受体。血管紧张素转换酶II的绝大多数作用是由AT1受体介导的，包括细胞增殖、血管收缩和抗心绞痛。人们对AT2受体的功能知之甚少。最近的研究表明，AT2受体抑制细胞生长并诱导血管扩张，与血管紧张素转换酶II在AT1受体上的作用相反。AT2受体在体液和电解质动态平衡中的作用尚不清楚。首席调查员有初步数据表明，AT2受体介导正常SpragueDawley大鼠的钠尿，Ang II的七肽衍生物Des-Aspartyl-Ang II(Ang III)是首选的激动剂。首席调查者也有强有力的初步数据表明，刺激多巴胺D1受体可诱导肾近端小管细胞顶膜AT2受体表达增加，抑制AT2受体可取消D1受体诱导的钠尿。本项目将深入探讨AT2受体诱导性钠尿的部位和机制。该项目将集中于两个具体的假设：(1)肾近端小管上的AT2受体是Ang III、AT1受体阻断、D1受体激活和肾脏灌流压升高的钠尿反应的关键介质；(2)AT2受体介导的钠尿在年轻高血压前期自发性高血压大鼠(SHR)中存在缺陷。该项目将应用体内最先进的技术以及细胞和分子技术来阐明AT2受体在高血压钠排泄中的作用。这些研究将有助于阐明人类原发性高血压的病理生理学，这是一种影响西方世界四分之一成年后人口的疾病。